80 related articles for article (PubMed ID: 6161801)
1. Demonstration of a primary antidiuretic action of angiotensin II: effects of intrarenal converting enzyme inhibition in the conscious dog.
Levens NR; Peach MJ; Vaughan ED; Carey RM
Endocrinology; 1981 Jan; 108(1):318-30. PubMed ID: 6161801
[TBL] [Abstract][Full Text] [Related]
2. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs.
Kimbrough HM; Vaughan ED; Carey RM; Ayers CR
Circ Res; 1977 Feb; 40(2):174-8. PubMed ID: 191213
[TBL] [Abstract][Full Text] [Related]
3. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats.
Harris PJ; Munro JO
J Physiol; 1984 Jun; 351():491-500. PubMed ID: 6205144
[TBL] [Abstract][Full Text] [Related]
4. Renal sensitivity to angiotensin II in the conscious dog.
Siragy HM; Lamb NE; Woodson JF; Ragsdale NV; Rose CE; Peach MJ; Carey RM
Endocrinology; 1987 Apr; 120(4):1272-8. PubMed ID: 3549257
[TBL] [Abstract][Full Text] [Related]
5. Combined intrarenal blockade of the renin-angiotensin system in the conscious dog.
Siragy HM; Howell NL; Peach MJ; Carey RM
Am J Physiol; 1990 Mar; 258(3 Pt 2):F522-9. PubMed ID: 2180318
[TBL] [Abstract][Full Text] [Related]
6. Control of renal function by intrarenal angiotensin II.
Levens NR; Freedlender AE; Peach MJ; Carey RM
Endocrinology; 1983 Jan; 112(1):43-9. PubMed ID: 6847833
[TBL] [Abstract][Full Text] [Related]
7. Control of renal function by intrarenal angiotensin II in the dog.
Levens NR
J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S65-9. PubMed ID: 1705631
[TBL] [Abstract][Full Text] [Related]
8. Physiological responses to angiotensin II infusion during chronic angiotensin converting enzyme inhibition in dogs on normal, low and high sodium intake.
Olsen ME; Meydrech EF
J Hypertens; 1985 Oct; 3(5):517-25. PubMed ID: 2999230
[TBL] [Abstract][Full Text] [Related]
9. Combined intrarenal renin-angiotensin blockade alters renal function and this is reversed by angiotensin II.
Siragy HM; Howell NL; Peach MJ; Carey RM
J Hypertens Suppl; 1989 Dec; 7(6):S174-5. PubMed ID: 2698923
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
Bak M; Shalmi M; Petersen JS; Poulsen LB; Christensen S
J Pharmacol Exp Ther; 1993 Jul; 266(1):33-40. PubMed ID: 8392557
[TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin II on renal water excretion.
Cadnapaphornchai P; Boykin J; Harbottle JA; McDonald KM; Schrier RW
Am J Physiol; 1975 Jan; 228(1):155-9. PubMed ID: 1147006
[TBL] [Abstract][Full Text] [Related]
12. No effect of intrarenal converting enzyme inhibition on canine renal blood flow.
Zimmerman BG; Wong PC; Kounenis GK; Kraft EJ
Am J Physiol; 1982 Aug; 243(2):H277-83. PubMed ID: 6180643
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin and angiotensin II in the conscious dog: synergistic effects on renal excretory parameters?
Eiken P; Emmeluth C; Schütten HJ; Bie P
Clin Sci (Lond); 1992 Oct; 83(4):467-75. PubMed ID: 1330410
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin II on plasma antidiuretic hormone and renal water excretion.
Henrich WL; Walker BR; Handelman WA; Erickson AL; Arnold PE; Schrier RW
Kidney Int; 1986 Oct; 30(4):503-8. PubMed ID: 3784290
[TBL] [Abstract][Full Text] [Related]
15. Escape from the sodium-retaining action of intrarenal angiotensins II and III in the conscious dog.
Dickstein GM; Woodson JF; Lamb NE; Rose CE; Peach MJ; Carey RM
Endocrinology; 1985 Nov; 117(5):2160-9. PubMed ID: 4042980
[TBL] [Abstract][Full Text] [Related]
16. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs.
Abe Y; Miura K; Imanishi M; Yukimura T; Komori T; Okahara T; Yamamoto K
J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237
[TBL] [Abstract][Full Text] [Related]
17. Comparison of systemic and intrarenal converting enzyme inhibition by MK-422 on renal hemodynamics in conscious dogs.
Zimmerman BG; Finis CJ
J Cardiovasc Pharmacol; 1985; 7(4):715-22. PubMed ID: 2410713
[TBL] [Abstract][Full Text] [Related]
18. Glomerular and renal hemodynamics during converting enzyme inhibition (SQ20,881) in the dog.
Navar LG; LaGrange RA; Bell PD; Thomas CE; Ploth DW
Hypertension; 1979; 1(4):371-7. PubMed ID: 396240
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of renal sodium reabsorption by angiotensin II.
Johnson MD; Malvin RL
Am J Physiol; 1977 Apr; 232(4):F298-306. PubMed ID: 851187
[TBL] [Abstract][Full Text] [Related]
20. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
Clark KL; Hilditch A; Robertson MJ; Drew GM
J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
